logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • SpecGx LLC drugs

    FiltersReset Filters
    43 results

    • acetaminophen and codeine phosphate

      (acetaminophen and codeine phosphate)
      SpecGx LLC
      Usage: Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain when alternative treatments are inadequate. Use is limited due to risks of addiction, abuse, and misuse, and they should not be used long-term unless necessary.

    • acetaminophen and codeine phosphate

      (Acetaminophen And Codeine Phosphate)
      SpecGx LLC

    • amitiza - lubiprostone capsule, gelatin coated

      (Lubiprostone)
      Specgx Llc

    • amphetamine sulfate

      (Amphetamine Sulfate)
      SpecGx LLC
      Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity as part of a comprehensive treatment approach, and short-term management of exogenous obesity in patients not responding to other weight reduction therapies.

    • anafranil - clomipramine hydrochloride capsule

      (Clomipramine Hydrochloride)
      Specgx Llc

    • buprenorphine hydrochloride and naloxone hydrochloride dihydrate

      (Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate)
      SpecGx LLC
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.

    • clomipramine hydrochloride - clomipramine hydrochloride capsule

      (Clomipramine Hydrochloride)
      Specgx Llc

    • dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate

      (dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate)
      SpecGx LLC
      Usage: Mixed Salts of a Single Entity Amphetamine Product is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy, addressing symptoms that impair functioning in various settings and are present from a young age.

    • dextroamphetamine sulfate

      (dextroamphetamine sulfate)
      SpecGx LLC
      Usage: Dextroamphetamine sulfate extended-release capsules are indicated for the treatment of narcolepsy and Attention Deficit Disorder with Hyperactivity (ADHD) in children aged 6 to 16. It's part of a comprehensive treatment plan that includes psychological, educational, and social interventions.

    • dextroamphetamine sulfate - dextroamphetamine sulfate tablet

      (Dextroamphetamine Sulfate)
      Specgx Llc